CIBC Bancorp USA
EDIT icon

CIBC Bancorp USA’s Editas Medicine EDIT Stock Holding History

CIBC Bancorp USA’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$39.9K Buy
+15,507
New +$45.4K ﹤0.01% 2190
2026
Q2 		– Sell
-12,255
Closed -$30.3K – 1964
2026
Q1 		$30.3K Buy
+12,255
New +$25.9K ﹤0.01% 1729

Other funds holding EDIT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

CIBC Bancorp USA's EDIT Position: Q3 2026 in Review

CIBC Bancorp USA opened a new position in Editas Medicine (EDIT) in Q3 2026: 15,507 shares worth $39.9K. The stake represents ﹤0.01% of the portfolio and ranks #2190 among its holdings. This is a return to the name: CIBC Bancorp USA previously reported a position in EDIT as recently as Q1 2026.

CIBC Bancorp USA first reported a position in EDIT in Q1 2026 and has held it in 2 quarters since. 162 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • CIBC Bancorp USA held 15,507 shares of Editas Medicine worth $39.9K as of Q3 2026.
  • Editas Medicine was a new CIBC Bancorp USA position in Q3 2026.
  • Editas Medicine made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #2190 holding.
  • CIBC Bancorp USA first reported a position in Editas Medicine in Q1 2026 and has held it in 2 quarters since.
  • 162 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.